Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. BIOAF


Primary Symbol: V.BTI

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by Boomskidon Aug 24, 2023 1:02am
42 Views
Post# 35603158

RE:RE:TT's Sappy Cap Plot

RE:RE:TT's Sappy Cap PlotHave they passed on xB3? Besides Chiesi, who passed? 

Did Chiesi and Protalix understand how to make fusion proteins with xB3?

Other companies have. MedImmune understood it.

Did Prothena have a payload that was worth advancing? I question that. And I know why I question it.

Why did LT, The Placee, Midatech, DrDR and Brother Mario want to buy Bioasis?

What did/does Bioasis have other than xB3?

The EGF stuff is worthless without xB3.

What was LT's play?

YOU DON'T HAVE AN ANSWER, Little TT.

jd
<< Previous
Bullboard Posts
Next >>